BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 230 filers reported holding BEAM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,871,522 | -29.3% | 119,398 | -6.1% | 0.00% | 0.0% |
Q2 2023 | $4,061,688 | +148.9% | 127,206 | +138.7% | 0.00% | 0.0% |
Q1 2023 | $1,631,587 | -69.9% | 53,285 | -61.6% | 0.00% | -50.0% |
Q4 2022 | $5,424,752 | +1294.5% | 138,705 | +1600.0% | 0.00% | – |
Q3 2022 | $389,000 | -74.6% | 8,159 | -79.4% | 0.00% | -100.0% |
Q2 2022 | $1,531,000 | -59.4% | 39,552 | -39.9% | 0.00% | 0.0% |
Q1 2022 | $3,768,000 | +22.5% | 65,758 | +70.4% | 0.00% | 0.0% |
Q4 2021 | $3,075,000 | -27.5% | 38,584 | -20.9% | 0.00% | 0.0% |
Q3 2021 | $4,241,000 | +13.7% | 48,751 | +68.3% | 0.00% | 0.0% |
Q2 2021 | $3,729,000 | -47.1% | 28,970 | -67.1% | 0.00% | -50.0% |
Q1 2021 | $7,054,000 | +297.2% | 88,129 | +305.1% | 0.00% | +100.0% |
Q4 2020 | $1,776,000 | +1514.5% | 21,756 | +387.7% | 0.00% | – |
Q3 2020 | $110,000 | -45.8% | 4,461 | -38.3% | 0.00% | – |
Q2 2020 | $203,000 | +1350.0% | 7,235 | +804.4% | 0.00% | – |
Q1 2020 | $14,000 | – | 800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |